Wearable gadget could protect dialysis Patients' hearts and brains

NCT ID NCT06832696

Not yet recruiting Disease control Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new wearable device that gently removes extra fluid between dialysis sessions. Many dialysis patients struggle with fluid buildup because standard treatments remove it too quickly, causing heart and brain damage. The device is worn at home for a few hours after dialysis. The study will check if it works, is comfortable, and can be used safely in 18 adults on dialysis.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: wearable residual ultrafiltration device (RUF-D)
What this could lead to: If successful, this could lead to a way for dialysis patients to safely remove extra fluid at home between sessions, potentially reducing organ damage and improving survival.
What could go wrong: This is a very early, small study (18 people) testing only if the device works and is comfortable. It may not prove any health benefits, and there are risks like infection or device malfunction.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMODIALYSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

kidney failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEMODIALYSIS ULTRAFILTRATION

Contacts and locations

Locations

London Health Sciences Centre

London, Ontario, N6A 5W9, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.